Structure Identification and Risk Assurance of Unknown Impurities in Pramipexole Oral Drug Formulation
RR Tjandrawinata, AH Cahyana… - Advances in …, 2024 - Wiley Online Library
Impurities compounds in any pharmaceutical product or drug substance are inevitable from
a chemistry point of view. The quality and safety of a pharmaceutical product are also …
a chemistry point of view. The quality and safety of a pharmaceutical product are also …
Deciphering the Molecular Basis of Mutated Binding Site Bromodomain-Ligand Complexes: Insights from Molecular Dynamics Simulations and Decoded Interaction …
FD Riandono - Jurnal Ilmu Farmasi dan Farmasi …, 2023 - publikasiilmiah.unwahas.ac.id
This study aims to predict structural stability changes and to identify the molecular
determinants of ligand-bromodomain complex interactions that undergo mutations in the …
determinants of ligand-bromodomain complex interactions that undergo mutations in the …
VALIDASI INTERNAL KOMPLEKS RESEPTOR HMG-COA REDUKTASE (PDB: 1HWK)-ATORVASTATIN SEBAGAI ANTIKOLESTEROL DENGAN METODE …
G Nugraha, S Suprayetno… - Babul Ilmi …, 2022 - jurnal.stikes-aisyiyah-palembang.ac …
Abstract Latar Belakang: Penyakit hiperlipidemia cenderung terjadi pada kelompok usia
produktif dari umur 25 tahun keatas, tanpa pengobatan yang tepat dapat menyebabkan …
produktif dari umur 25 tahun keatas, tanpa pengobatan yang tepat dapat menyebabkan …